» Articles » PMID: 25277149

Volumetric Fat Ratio and Not Body Mass Index is Predictive of Ileocolectomy Outcomes in Crohn's Disease Patients

Overview
Journal Dig Surg
Date 2014 Oct 4
PMID 25277149
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Crohn's disease (CD) patients are typically underweight; however, a growing cohort of overweight CD patients is emerging. The current study investigates whether body mass index (BMI) or volumetric fat parameters can be used to predict morbidity after ileocolectomy for CD.

Methods: One hundred and forty-three CD patients who underwent elective ileocolectomy were identified from our Inflammatory Bowel Disease (IBD) Registry. Patient demographics and operative outcomes were recorded. Visceral (VA) and subcutaneous (SA) adiposity and abdominal circumference (AC) were analyzed on preoperative CT scans using Aquarius iNtuition software. A visceral/subcutaneous ratio (VSR) was calculated.

Results: BMI correlated with SA (p = 0.0001), VA (p = 0.0001) and AC (p = 0.0001) but not VSR (p > 0.05). BMI, VA and AC did not predict surgical morbidity (p > 0.05). In multivariate regression analysis, family history of IBD (p = 0.009), high American Society of Anesthesiologists score (p = 0.02) and increased VSR (p = 0.03) were independent predictors of postoperative morbidity.

Conclusions: The visceral/subcutaneous fat ratio is a more reliable predictor of postoperative outcomes in CD patients undergoing ileocolectomy than conventional adiposity markers such as BMI. Preoperative calculation of the visceral/subcutaneous fat ratio offers the opportunity to optimize high-risk surgical patients, thus improving outcomes.

Citing Articles

To cut or not to cut? Extended mesenteric excision during intestinal resection does not impact the postoperative recurrence nor the postoperative complications in Crohn's disease: a systematic review and meta-analysis.

Topala M, Martinekova P, Rancz A, Veres D, Lenti K, Miheller P Tech Coloproctol. 2025; 29(1):79.

PMID: 40057619 PMC: 11890256. DOI: 10.1007/s10151-025-03110-w.


Assessment of body composition-related imaging parameters indicative of sarcopenia in Chinese patients with Crohn's disease: correlation with disease severity and biologic efficacy.

Xie C, Qian W, Shang L, Wang X, Zhang J, Ma X Am J Transl Res. 2024; 16(10):5427-5440.

PMID: 39544770 PMC: 11558411. DOI: 10.62347/ZPZR8134.


Navigating the Intersection: Sarcopenia and Sarcopenic Obesity in Inflammatory Bowel Disease.

Calvez V, Becherucci G, Covello C, Piccirilli G, Mignini I, Esposto G Biomedicines. 2024; 12(6).

PMID: 38927425 PMC: 11200968. DOI: 10.3390/biomedicines12061218.


CT-based radiomics signature of visceral adipose tissue and bowel lesions for identifying patients with Crohn's disease resistant to infliximab.

Wang Y, Luo Z, Zhou Z, Zhong Y, Zhang R, Shen X Insights Imaging. 2024; 15(1):28.

PMID: 38289416 PMC: 10828370. DOI: 10.1186/s13244-023-01581-9.


Viscoelastic properties of small bowel mesentery at MR elastography in Crohn's disease: a prospective cross-sectional exploratory study.

van Schelt A, Beek K, Wassenaar N, Schrauben E, Runge J, Gecse K Eur Radiol Exp. 2023; 7(1):53.

PMID: 37718360 PMC: 10505604. DOI: 10.1186/s41747-023-00366-5.